Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.